These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 9489527)

  • 41. Cognitive predictors of dementia in Parkinson's disease: a community-based, 4-year longitudinal study.
    Janvin CC; Aarsland D; Larsen JP
    J Geriatr Psychiatry Neurol; 2005 Sep; 18(3):149-54. PubMed ID: 16100104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia.
    Kim JS; Youn J; Suh MK; Kim TE; Chin J; Park S; Cho JW
    Can J Neurol Sci; 2015 Nov; 42(6):395-400. PubMed ID: 26551089
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sleep spindles in Parkinson's disease may predict the development of dementia.
    Latreille V; Carrier J; Lafortune M; Postuma RB; Bertrand JA; Panisset M; Chouinard S; Gagnon JF
    Neurobiol Aging; 2015 Feb; 36(2):1083-90. PubMed ID: 25442116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Predictors of neuropsychological outcome in patients following microelectrode-guided pallidotomy for Parkinson's disease.
    Obwegeser AA; Uitti RJ; Lucas JA; Witte RJ; Turk MF; Wharen RE
    J Neurosurg; 2000 Sep; 93(3):410-20. PubMed ID: 10969938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuropsychological impairments associated with severity of Parkinson's disease.
    Huber SJ; Freidenberg DL; Shuttleworth EC; Paulson GW; Christy JA
    J Neuropsychiatry Clin Neurosci; 1989; 1(2):154-8. PubMed ID: 2521056
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Parkinson disease and cognition].
    Kulisevsky J; Pascual-Sedano B
    Neurologia; 1999 May; 14 Suppl 1():72-81. PubMed ID: 10377731
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cognitive impairment and dementia in Parkinson's disease: a controlled study.
    Boyd JL; Cruickshank CA; Kenn CW; Madeley P; Mindham RH; Oswald AG; Smith RJ; Spokes EG
    Psychol Med; 1991 Nov; 21(4):911-21. PubMed ID: 1780404
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Montreal Cognitive Assessment for the screening and prediction of cognitive decline in early Parkinson's disease.
    Kandiah N; Zhang A; Cenina AR; Au WL; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1145-8. PubMed ID: 25176439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Memory, mood, and vitamin D in persons with Parkinson's disease.
    Peterson AL; Murchison C; Zabetian C; Leverenz JB; Watson GS; Montine T; Carney N; Bowman GL; Edwards K; Quinn JF
    J Parkinsons Dis; 2013; 3(4):547-55. PubMed ID: 24081441
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Incidence of dementia in Parkinson disease].
    Sławek J; Bojko E; Szady J
    Neurol Neurochir Pol; 2001; 35(4):569-81. PubMed ID: 11783401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined effect of age and severity on the risk of dementia in Parkinson's disease.
    Levy G; Schupf N; Tang MX; Cote LJ; Louis ED; Mejia H; Stern Y; Marder K
    Ann Neurol; 2002 Jun; 51(6):722-9. PubMed ID: 12112078
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk factors for dementia in Parkinson's disease: effect of education.
    Glatt SL; Hubble JP; Lyons K; Paolo A; Tröster AI; Hassanein RE; Koller WC
    Neuroepidemiology; 1996; 15(1):20-5. PubMed ID: 8719045
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
    Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
    Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson's disease.
    Kandiah N; Zainal NH; Narasimhalu K; Chander RJ; Ng A; Mak E; Au WL; Sitoh YY; Nadkarni N; Tan LC
    Parkinsonism Relat Disord; 2014 Nov; 20(11):1203-8. PubMed ID: 25258331
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Attentional deficits in Alzheimer's, Parkinson's, and Huntington's diseases.
    Claus JJ; Mohr E
    Acta Neurol Scand; 1996 May; 93(5):346-51. PubMed ID: 8800345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cognitive impairments in advanced PD without dementia.
    Green J; McDonald WM; Vitek JL; Evatt M; Freeman A; Haber M; Bakay RA; Triche S; Sirockman B; DeLong MR
    Neurology; 2002 Nov; 59(9):1320-4. PubMed ID: 12427877
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations.
    Santangelo G; Trojano L; Vitale C; Ianniciello M; Amboni M; Grossi D; Barone P
    Mov Disord; 2007 Dec; 22(16):2418-25. PubMed ID: 17894370
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Survival in Parkinson's disease. Relation with motor and non-motor features.
    de Lau LM; Verbaan D; Marinus J; van Hilten JJ
    Parkinsonism Relat Disord; 2014 Jun; 20(6):613-6. PubMed ID: 24679900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.